Prelude Therapeutics (PRLD) Treasury Shares (2019 - 2020)

Prelude Therapeutics has reported Treasury Shares for 8 years, with the latest figure at $439080.0 in Q1 2026.

• Quarterly Treasury Shares rose 14.08% year-over-year to $439080.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $439080.0 (up 14.08% YoY) and the FY2025 annual result came in at $220500.0, up 292.0% from the prior year.
• Treasury Shares advanced to $439080.0 in Q1 2026 per PRLD's latest filing, from $220500.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $514641.0 in Q1 2022 and troughed at $56250.0 in Q4 2024.
• A 5-year average of $225291.7 and a median of $201716.0 in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2023 and 2025: Treasury Shares sank 68.18% in 2023, then soared 313.29% in 2025.
• Over 5 years, Treasury Shares stood at $201716.0 in 2022, then sank by 48.57% to $103750.0 in 2023, then plunged by 45.78% to $56250.0 in 2024, then surged by 292.0% to $220500.0 in 2025, then jumped by 99.13% to $439080.0 in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $439080.0, $220500.0, and $292375.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.